Natural killer (NK) cells from ambulant COVID-19 patients showed increased production of IFN-γ, whereas NK cells from patients with severe COVID-19 produced only low levels of IFN-γ and TNF (Witkowski et al., 2021). This evidence concerns the gene IFNG and COVID-19.